---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-007051"
form_type: "8-K"
ticker: "MXCT"
cik: "0001287098"
company_name: "MAXCYTE, INC."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T16:37:30.973474+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MaxCyte Q1 revenue $11.3M (+32% YoY); updates 2024 SPL guidance to ~$5M

## Summary
- Total revenue $11.3M, up 32% YoY; core revenue $8.2M, up 5%.
- SPL program-related revenue $3.2M, up 292% YoY; four new SPLs signed YTD including Be Biopharma.
- Net loss $9.5M vs $10.9M in Q1 2023; EBITDA loss $11.2M.
- 2024 guidance: core revenue flat to 5% growth; SPL revenue expected ~$5M (increase).
- Cash and investments $202.5M at March 31; expects year-end cash at least $175M.

## SEC filing metadata
- accession: 0001558370-24-007051
- form_type: 8-K
- ticker: MXCT
- cik: 0001287098
- company_name: MAXCYTE, INC.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1287098/000155837024007051/0001558370-24-007051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1287098/000155837024007051/mxct-20240507x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-007051
- JSON: https://secwatch.observer/filing/0001558370-24-007051.json
- Plain text: https://secwatch.observer/filing/0001558370-24-007051.txt

## Key facts
- Earnings Releases
  MAXCYTE, INC. reported the quarter ended March 31, 2024 results: revenue $11.3 million, net income $9.5 million. Guidance raised.
  - Period: the quarter ended March 31, 2024
  - Revenue: $11.3 million
  - Net income: $9.5 million
  - Guidance: raised
  - Result: reported results
  source text: applications, today announced its first quarter ended March 31, 2024 financial results and updated its 2024 guidance. ​ First Quarter Highlights ​ · Total revenue of $11.3 million in the first quarter of 2024, an increase of 32% over the first quarter of 2023. · Core business revenue of $8.2 million in the first quarter of 2024, an increase of 5% over the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1287098/000155837024007051/0001558370-24-007051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.